Report cover image

Global Cas9 Nuclease Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 204 Pages
SKU # APRC20283265

Description

Summary

According to APO Research, The global Cas9 Nuclease market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Cas9 Nuclease is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Cas9 Nuclease is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Cas9 Nuclease is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Cas9 Nuclease is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Cas9 Nuclease include SBS Genetech, Novoprotein, Agilent, Thermo Fisher Scientific, Stemcell Technologies, Sigma-Aldrich, OriGene Technologies, Nippon Gene and New England Biolabs, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Cas9 Nuclease, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Cas9 Nuclease, also provides the sales of main regions and countries. Of the upcoming market potential for Cas9 Nuclease, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cas9 Nuclease sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Cas9 Nuclease market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Cas9 Nuclease sales, projected growth trends, production technology, application and end-user industry.

Cas9 Nuclease Segment by Company

SBS Genetech
Novoprotein
Agilent
Thermo Fisher Scientific
Stemcell Technologies
Sigma-Aldrich
OriGene Technologies
Nippon Gene
New England Biolabs
Kactus
Horizo​​n Discovery
GenScript
Danaher
BPS Bioscience
Applied Biological Materials
Abnova
Cas9 Nuclease Segment by Type

Cas9 mRNA
Cas9 Protein
Cas9 Lentivirus
Cas9 Plasmid
Cas9 Nuclease Segment by Application

Bioagriculture
Gene Therapy
Gene Editing Cell Line Construction
Animal Models
Other
Cas9 Nuclease Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cas9 Nuclease market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cas9 Nuclease and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cas9 Nuclease.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Cas9 Nuclease in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Cas9 Nuclease manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cas9 Nuclease sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

204 Pages
1 Market Overview
1.1 Product Definition
1.2 Cas9 Nuclease Market by Type
1.2.1 Global Cas9 Nuclease Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Cas9 mRNA
1.2.3 Cas9 Protein
1.2.4 Cas9 Lentivirus
1.2.5 Cas9 Plasmid
1.3 Cas9 Nuclease Market by Application
1.3.1 Global Cas9 Nuclease Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Bioagriculture
1.3.3 Gene Therapy
1.3.4 Gene Editing Cell Line Construction
1.3.5 Animal Models
1.3.6 Other
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Cas9 Nuclease Market Dynamics
2.1 Cas9 Nuclease Industry Trends
2.2 Cas9 Nuclease Industry Drivers
2.3 Cas9 Nuclease Industry Opportunities and Challenges
2.4 Cas9 Nuclease Industry Restraints
3 Global Market Growth Prospects
3.1 Global Cas9 Nuclease Revenue Estimates and Forecasts (2020-2031)
3.2 Global Cas9 Nuclease Revenue by Region
3.2.1 Global Cas9 Nuclease Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Cas9 Nuclease Revenue by Region (2020-2025)
3.2.3 Global Cas9 Nuclease Revenue by Region (2026-2031)
3.2.4 Global Cas9 Nuclease Revenue Market Share by Region (2020-2031)
3.3 Global Cas9 Nuclease Sales Estimates and Forecasts 2020-2031
3.4 Global Cas9 Nuclease Sales by Region
3.4.1 Global Cas9 Nuclease Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Cas9 Nuclease Sales by Region (2020-2025)
3.4.3 Global Cas9 Nuclease Sales by Region (2026-2031)
3.4.4 Global Cas9 Nuclease Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global Cas9 Nuclease Revenue by Manufacturers
4.1.1 Global Cas9 Nuclease Revenue by Manufacturers (2020-2025)
4.1.2 Global Cas9 Nuclease Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global Cas9 Nuclease Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global Cas9 Nuclease Sales by Manufacturers
4.2.1 Global Cas9 Nuclease Sales by Manufacturers (2020-2025)
4.2.2 Global Cas9 Nuclease Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global Cas9 Nuclease Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global Cas9 Nuclease Sales Price by Manufacturers (2020-2025)
4.4 Global Cas9 Nuclease Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global Cas9 Nuclease Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Cas9 Nuclease Manufacturers, Product Type & Application
4.7 Global Cas9 Nuclease Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global Cas9 Nuclease Market CR5 and HHI
4.8.2 2024 Cas9 Nuclease Tier 1, Tier 2, and Tier 3
5 Cas9 Nuclease Market by Type
5.1 Global Cas9 Nuclease Revenue by Type
5.1.1 Global Cas9 Nuclease Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global Cas9 Nuclease Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global Cas9 Nuclease Revenue Market Share by Type (2020-2031)
5.2 Global Cas9 Nuclease Sales by Type
5.2.1 Global Cas9 Nuclease Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global Cas9 Nuclease Sales by Type (2020-2031) & (K Units)
5.2.3 Global Cas9 Nuclease Sales Market Share by Type (2020-2031)
5.3 Global Cas9 Nuclease Price by Type
6 Cas9 Nuclease Market by Application
6.1 Global Cas9 Nuclease Revenue by Application
6.1.1 Global Cas9 Nuclease Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global Cas9 Nuclease Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global Cas9 Nuclease Revenue Market Share by Application (2020-2031)
6.2 Global Cas9 Nuclease Sales by Application
6.2.1 Global Cas9 Nuclease Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global Cas9 Nuclease Sales by Application (2020-2031) & (K Units)
6.2.3 Global Cas9 Nuclease Sales Market Share by Application (2020-2031)
6.3 Global Cas9 Nuclease Price by Application
7 Company Profiles
7.1 SBS Genetech
7.1.1 SBS Genetech Comapny Information
7.1.2 SBS Genetech Business Overview
7.1.3 SBS Genetech Cas9 Nuclease Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 SBS Genetech Cas9 Nuclease Product Portfolio
7.1.5 SBS Genetech Recent Developments
7.2 Novoprotein
7.2.1 Novoprotein Comapny Information
7.2.2 Novoprotein Business Overview
7.2.3 Novoprotein Cas9 Nuclease Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Novoprotein Cas9 Nuclease Product Portfolio
7.2.5 Novoprotein Recent Developments
7.3 Agilent
7.3.1 Agilent Comapny Information
7.3.2 Agilent Business Overview
7.3.3 Agilent Cas9 Nuclease Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Agilent Cas9 Nuclease Product Portfolio
7.3.5 Agilent Recent Developments
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Comapny Information
7.4.2 Thermo Fisher Scientific Business Overview
7.4.3 Thermo Fisher Scientific Cas9 Nuclease Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Thermo Fisher Scientific Cas9 Nuclease Product Portfolio
7.4.5 Thermo Fisher Scientific Recent Developments
7.5 Stemcell Technologies
7.5.1 Stemcell Technologies Comapny Information
7.5.2 Stemcell Technologies Business Overview
7.5.3 Stemcell Technologies Cas9 Nuclease Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Stemcell Technologies Cas9 Nuclease Product Portfolio
7.5.5 Stemcell Technologies Recent Developments
7.6 Sigma-Aldrich
7.6.1 Sigma-Aldrich Comapny Information
7.6.2 Sigma-Aldrich Business Overview
7.6.3 Sigma-Aldrich Cas9 Nuclease Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Sigma-Aldrich Cas9 Nuclease Product Portfolio
7.6.5 Sigma-Aldrich Recent Developments
7.7 OriGene Technologies
7.7.1 OriGene Technologies Comapny Information
7.7.2 OriGene Technologies Business Overview
7.7.3 OriGene Technologies Cas9 Nuclease Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 OriGene Technologies Cas9 Nuclease Product Portfolio
7.7.5 OriGene Technologies Recent Developments
7.8 Nippon Gene
7.8.1 Nippon Gene Comapny Information
7.8.2 Nippon Gene Business Overview
7.8.3 Nippon Gene Cas9 Nuclease Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Nippon Gene Cas9 Nuclease Product Portfolio
7.8.5 Nippon Gene Recent Developments
7.9 New England Biolabs
7.9.1 New England Biolabs Comapny Information
7.9.2 New England Biolabs Business Overview
7.9.3 New England Biolabs Cas9 Nuclease Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 New England Biolabs Cas9 Nuclease Product Portfolio
7.9.5 New England Biolabs Recent Developments
7.10 Kactus
7.10.1 Kactus Comapny Information
7.10.2 Kactus Business Overview
7.10.3 Kactus Cas9 Nuclease Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Kactus Cas9 Nuclease Product Portfolio
7.10.5 Kactus Recent Developments
7.11 Horizo​​n Discovery
7.11.1 Horizo​​n Discovery Comapny Information
7.11.2 Horizo​​n Discovery Business Overview
7.11.3 Horizo​​n Discovery Cas9 Nuclease Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Horizo​​n Discovery Cas9 Nuclease Product Portfolio
7.11.5 Horizo​​n Discovery Recent Developments
7.12 GenScript
7.12.1 GenScript Comapny Information
7.12.2 GenScript Business Overview
7.12.3 GenScript Cas9 Nuclease Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 GenScript Cas9 Nuclease Product Portfolio
7.12.5 GenScript Recent Developments
7.13 Danaher
7.13.1 Danaher Comapny Information
7.13.2 Danaher Business Overview
7.13.3 Danaher Cas9 Nuclease Sales, Revenue, Price and Gross Margin (2020-2025)
7.13.4 Danaher Cas9 Nuclease Product Portfolio
7.13.5 Danaher Recent Developments
7.14 BPS Bioscience
7.14.1 BPS Bioscience Comapny Information
7.14.2 BPS Bioscience Business Overview
7.14.3 BPS Bioscience Cas9 Nuclease Sales, Revenue, Price and Gross Margin (2020-2025)
7.14.4 BPS Bioscience Cas9 Nuclease Product Portfolio
7.14.5 BPS Bioscience Recent Developments
7.15 Applied Biological Materials
7.15.1 Applied Biological Materials Comapny Information
7.15.2 Applied Biological Materials Business Overview
7.15.3 Applied Biological Materials Cas9 Nuclease Sales, Revenue, Price and Gross Margin (2020-2025)
7.15.4 Applied Biological Materials Cas9 Nuclease Product Portfolio
7.15.5 Applied Biological Materials Recent Developments
7.16 Abnova
7.16.1 Abnova Comapny Information
7.16.2 Abnova Business Overview
7.16.3 Abnova Cas9 Nuclease Sales, Revenue, Price and Gross Margin (2020-2025)
7.16.4 Abnova Cas9 Nuclease Product Portfolio
7.16.5 Abnova Recent Developments
8 North America
8.1 North America Cas9 Nuclease Market Size by Type
8.1.1 North America Cas9 Nuclease Revenue by Type (2020-2031)
8.1.2 North America Cas9 Nuclease Sales by Type (2020-2031)
8.1.3 North America Cas9 Nuclease Price by Type (2020-2031)
8.2 North America Cas9 Nuclease Market Size by Application
8.2.1 North America Cas9 Nuclease Revenue by Application (2020-2031)
8.2.2 North America Cas9 Nuclease Sales by Application (2020-2031)
8.2.3 North America Cas9 Nuclease Price by Application (2020-2031)
8.3 North America Cas9 Nuclease Market Size by Country
8.3.1 North America Cas9 Nuclease Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America Cas9 Nuclease Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America Cas9 Nuclease Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
8.3.6 Mexico
9 Europe
9.1 Europe Cas9 Nuclease Market Size by Type
9.1.1 Europe Cas9 Nuclease Revenue by Type (2020-2031)
9.1.2 Europe Cas9 Nuclease Sales by Type (2020-2031)
9.1.3 Europe Cas9 Nuclease Price by Type (2020-2031)
9.2 Europe Cas9 Nuclease Market Size by Application
9.2.1 Europe Cas9 Nuclease Revenue by Application (2020-2031)
9.2.2 Europe Cas9 Nuclease Sales by Application (2020-2031)
9.2.3 Europe Cas9 Nuclease Price by Application (2020-2031)
9.3 Europe Cas9 Nuclease Market Size by Country
9.3.1 Europe Cas9 Nuclease Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe Cas9 Nuclease Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe Cas9 Nuclease Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
9.3.9 Spain
9.3.10 Netherlands
10 China
10.1 China Cas9 Nuclease Market Size by Type
10.1.1 China Cas9 Nuclease Revenue by Type (2020-2031)
10.1.2 China Cas9 Nuclease Sales by Type (2020-2031)
10.1.3 China Cas9 Nuclease Price by Type (2020-2031)
10.2 China Cas9 Nuclease Market Size by Application
10.2.1 China Cas9 Nuclease Revenue by Application (2020-2031)
10.2.2 China Cas9 Nuclease Sales by Application (2020-2031)
10.2.3 China Cas9 Nuclease Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Cas9 Nuclease Market Size by Type
11.1.1 Asia Cas9 Nuclease Revenue by Type (2020-2031)
11.1.2 Asia Cas9 Nuclease Sales by Type (2020-2031)
11.1.3 Asia Cas9 Nuclease Price by Type (2020-2031)
11.2 Asia Cas9 Nuclease Market Size by Application
11.2.1 Asia Cas9 Nuclease Revenue by Application (2020-2031)
11.2.2 Asia Cas9 Nuclease Sales by Application (2020-2031)
11.2.3 Asia Cas9 Nuclease Price by Application (2020-2031)
11.3 Asia Cas9 Nuclease Market Size by Country
11.3.1 Asia Cas9 Nuclease Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia Cas9 Nuclease Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia Cas9 Nuclease Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Cas9 Nuclease Market Size by Type
12.1.1 SAMEA Cas9 Nuclease Revenue by Type (2020-2031)
12.1.2 SAMEA Cas9 Nuclease Sales by Type (2020-2031)
12.1.3 SAMEA Cas9 Nuclease Price by Type (2020-2031)
12.2 SAMEA Cas9 Nuclease Market Size by Application
12.2.1 SAMEA Cas9 Nuclease Revenue by Application (2020-2031)
12.2.2 SAMEA Cas9 Nuclease Sales by Application (2020-2031)
12.2.3 SAMEA Cas9 Nuclease Price by Application (2020-2031)
12.3 SAMEA Cas9 Nuclease Market Size by Country
12.3.1 SAMEA Cas9 Nuclease Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA Cas9 Nuclease Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA Cas9 Nuclease Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 Cas9 Nuclease Value Chain Analysis
13.1.1 Cas9 Nuclease Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Cas9 Nuclease Production Mode & Process
13.2 Cas9 Nuclease Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Cas9 Nuclease Distributors
13.2.3 Cas9 Nuclease Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.